Biote Corp. (BTMD)
Nasdaq: BTMD · Medicinal Chemicals & Botanical Products · Irving, TX · filing with the SEC since 2020
Grade4.8
◀ Past 4.6● Present 4.2▶ Future 5.6
Filings
274 filings since 2017 beside 139 insider forms · Accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and smaller reporting company and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 2, 2026.
Filings a yearinsider forms included
142122105594737
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Jun 17, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 2, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
May 27, 2026
Jun 9, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jun 5, 2025
May 7, 2025
8-K items 2.02, 2.05, 9.01
Results released; Exit or restructuring costs · Current report
May 1, 2025
40 of 274 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.